All News

2017

December

Media Release / Dec 08, 2017

Sandoz announces new Phase I data showing proposed biosimilar pegfilgrastim matches reference medicine

Read More

November

Media Release / Nov 15, 2017

Sandoz Scientific Standalone Event in Russia “Combat Infections to Save Lives”

Read More
Media Release / Nov 14, 2017

New data reinforces clinical basis for switching to Sandoz biosimilar medicines

Read More

October

Media Release / Oct 27, 2017

Sandoz proposed biosimilar pegfilgrastim accepted by EMA for regulatory review

Read More
Media Release / Oct 24, 2017

Novartis delivered growth on top and bottom line in all divisions in Q3

Read More

September

Media Release / Sep 14, 2017

Sandoz proposed biosimilar adalimumab matches reference biologic in terms of efficacy and safety in long-term study

Read More
Media Release / Sep 12, 2017

Sandoz proposed biosimilar rituximab accepted for review by the FDA

Read More

August

Media Release / Aug 29, 2017

Sandoz invests in major expansion of global headquarters in Holzkirchen, Germany

Read More
Media Release / Aug 29, 2017

Lancet Haematology publishes data demonstrating Sandoz Rixathon® (biosimilar rituximab) matches efficacy and safety of reference biologic

Read More

July

Media Release / Jul 25, 2017

Sandoz expands partnership with World Child Cancer, to help children access treatment in four developing countries

Read More

Pages